Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Chris Pasquale
Period: Reporting period mapped to calendar 2026 Q3.
- Questions
- 3on tracked calls
- Challenge rate
- 0%none of 3 questionsLimited sample
- Companies
- 2questioned at least once
- Reporting periods
- 1with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right. See how we grade analysts on earnings-call questions.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 3 of 3 questions from 2 companies
SYKStryker Corporation2 questions · 1 reporting period · 0 of 2 challenging
Calendar 2026 Q3
Are you saying you're just being more conservative about what's assumed between now and year-end
Show response
Confirmed it is conservatism about matching production to strong capital demand, not a demand issue.
Did some new dynamics emerge on the knee side in terms of your competitiveness in that segment?
Show response
Said share has been steady over 12 months but growth is now in line with market; pointed to Mako RPS, Triathlon Gold and MSI.
ISRGIntuitive Surgical1 question · 1 reporting period · 0 of 1 challenging
Calendar 2026 Q3
you talked about offsetting the gross margin headwind from extended use. Are there any other considerations
Show response
Jamie restated the 35% to 40% operating margin range and a lean to invest from today's 41%, 42%, deferring opex guidance to January.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| SYK Stryker Corporation | 2 | —Rate withheld: fewer than 3 questions |
| ISRG Intuitive Surgical | 1 | —Rate withheld: fewer than 3 questions |
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2026 Q3 | 3 | 0%none of 3 questions | 2 |
- 2026 Q33 questions · challenge rate 0% (none of 3 questions) · 2 companies
Topics
Topics tagged on this analyst’s questions.
- Margin1
- Innovation & R&D1
- Guidance Reliability1
- Capex Investment1
- Competitive Dynamics1
- Product Launch1